CSET’s Steph Batalis, Katherine Quinn, and Rebecca Gelles shared their expert analysis in an op-ed published by Barron's. Their piece examines the economic and scientific impact of proposed funding cuts to the National Institutes of Health (NIH), arguing that NIH-backed research plays a foundational role in driving medical innovation, biotechnology growth, and U.S. competitiveness.

CSET’s Vikram Venkatram shared his expert insight in an article published by Bloomberg News. The article examines China’s efforts to build massive domestic biobanks as access to Western biomedical databases becomes increasingly restricted amid growing geopolitical tensions.

CSET’s Steph Batalis shared her expert insight in an article published by TIME. The article examines how leading AI companies are increasingly restricting access to their most capable models, such as GPT-Rosalind and Claude Mythos, due to growing concerns around dual-use risks in areas like cybersecurity and biological research, and the broader question of who should govern access to these systems.

On March 25, CSET hosted a fireside chat with IQT’s Vice President of Technology, Dr. Jessica Dymond, to discuss the current state of emerging biotechnology, the promises it holds, and the steps that policymakers, investors, and practitioners can take to build a robust biotechnology sector.

Ambitious projects to accelerate AI-driven scientific discovery such as the Genesis Mission aim to unlock large federal datasets and incentivize private-sector participation. This blog examines how federal prize competitions—recognized in the Genesis Mission, the FY26 National Defense Authorization Act (NDAA), and recommendations from the National Security Commission on Emerging Biotechnology—can serve as effective implementation tools. Drawing on recent scientific prize competitions highlight lessons for designing incentives that advance national biotechnology and AI research priorities.

CSET submitted the following response to the White House Office of Science and Technology in support of its "Accelerating the American Scientific Enterprise initiative.

CSET’s Steph Batalis and Vikram Venkatram shared their expert analysis in an op-ed published by the Bulletin of the Atomic Scientists. The article discusses how rapidly advancing biotechnology and AI are reshaping biosecurity, highlighting both the promise of new scientific tools and the need for stronger, adaptive safeguards.

CSET’s Steph Batalis shared her expert analysis in an op-ed published by The National Interest. In her piece, she discusses how proposed federal research funding cuts threaten not only U.S. scientific progress but also the safety and security of biological research. These cuts would weaken the safeguards, oversight, and resources that protect both scientists and the public from accidents and biological threats.

This report examines lessons from the North Carolina Life Sciences Apprenticeship Consortium for pharmaceutical and biomanufacturing workforce development, and analyzes how apprenticeship programs help address workforce shortages in emerging tech fields. It offers a practical framework with important considerations for designing and launching programs, and serves as a resource for employers, regional leaders, and policymakers seeking to build a more resilient and technically skilled workforce.

Data Snapshots are informative descriptions and quick analyses that dig into CSET’s unique data resources. This three-part series introduces CSET’s patent clusters, which connect related patents through citations and text similarity.